HK1177228A1 - Lactic acid bacteria having action of lowering blood uric acid level - Google Patents
Lactic acid bacteria having action of lowering blood uric acid levelInfo
- Publication number
- HK1177228A1 HK1177228A1 HK13104508.2A HK13104508A HK1177228A1 HK 1177228 A1 HK1177228 A1 HK 1177228A1 HK 13104508 A HK13104508 A HK 13104508A HK 1177228 A1 HK1177228 A1 HK 1177228A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- action
- lowering blood
- blood uric
- lactic acid
- acid bacteria
- Prior art date
Links
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011104539332A CN102747004B (en) | 2007-11-29 | 2007-11-29 | Lactic acid bacteria with effect of uric acid level reducing in blood |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1177228A1 true HK1177228A1 (en) | 2013-08-16 |
Family
ID=47027499
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK13104508.2A HK1177228A1 (en) | 2007-11-29 | 2013-04-14 | Lactic acid bacteria having action of lowering blood uric acid level |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN102747004B (en) |
HK (1) | HK1177228A1 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103667124B (en) * | 2013-11-29 | 2015-08-05 | 内蒙古医科大学 | One strain has milk-acid bacteria and the screening method thereof of degraded creatinine and urea ability |
JP6524432B2 (en) * | 2014-05-29 | 2019-06-05 | 日東薬品工業株式会社 | Novel lactic acid bacteria and composition containing the lactic acid bacteria |
CN107028985A (en) * | 2016-02-04 | 2017-08-11 | 深圳华大基因研究院 | Application of the heavy wall mushroom probiotics in preventing and/or treating diabetes and its relevant disease |
CN106754479B (en) * | 2016-11-24 | 2019-11-08 | 浙江大学宁波理工学院 | A kind of lactobacillus curvatus and its application |
CN110184209B (en) * | 2019-04-24 | 2020-10-30 | 杭州娃哈哈科技有限公司 | Lactobacillus rhamnosus capable of reducing blood uric acid |
CN112458027B (en) * | 2020-12-16 | 2022-08-02 | 江南大学 | Lactobacillus gasseri and application thereof in relieving and treating hyperuricemia |
CN113249280B (en) * | 2021-07-16 | 2021-10-01 | 中科嘉亿营养医学(山东)微生态研究院有限公司 | Streptococcus thermophilus STN26, bacterium powder and application in uric acid reducing product |
CN113999805B (en) * | 2021-12-06 | 2022-05-17 | 四川高福记生物科技有限公司 | Lactobacillus fermentum for preventing and treating hyperuricemia, and composition and application thereof |
CN114908006B (en) * | 2022-04-25 | 2023-06-27 | 辽宁贝克瑞生物科技有限公司 | Lactobacillus gasseri and application thereof in reducing blood uric acid |
CN114908009B (en) * | 2022-05-10 | 2023-06-23 | 新疆农业大学 | Lactobacillus mucilaginosus PR63 and application thereof |
CN116024130B (en) * | 2022-12-13 | 2023-11-24 | 广西爱生生命科技有限公司 | Lactobacillus fermentum A21215 for reducing blood uric acid and application thereof |
-
2007
- 2007-11-29 CN CN2011104539332A patent/CN102747004B/en active Active
-
2013
- 2013-04-14 HK HK13104508.2A patent/HK1177228A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN102747004A (en) | 2012-10-24 |
CN102747004B (en) | 2013-11-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1152547A1 (en) | Lactic acid bacteria having action of lowering blood uric acid level | |
HK1155481A1 (en) | Lactic acid bacterium having effect of lowering blood uric acid level | |
HK1177228A1 (en) | Lactic acid bacteria having action of lowering blood uric acid level | |
HK1180337A1 (en) | Compounds useful in the modulation of blood uric acid levels | |
EP2136824A4 (en) | Use of selected lactic acid bacteria for reducing atherosclerosis | |
ZA200809531B (en) | Use of selected lactic acid bacteria for reducing infantile colic | |
HK1217293A1 (en) | Methods for the prevention or treatment of heart failure | |
EP2112219A4 (en) | Novel lactic acid bacteria | |
ZA201204031B (en) | Compounds, compositions and methods of using same for modulating uric acid levels | |
WO2010135536A9 (en) | Methods of modulating uric acid levels | |
EP2429609A4 (en) | Catheter insertion sterilization | |
IL194975A0 (en) | Composition and methods for treatment of congestive heart failure | |
EP2129369A4 (en) | Treatment of adhd | |
IL247136B (en) | Compounds for reducing uric acid and uses thereof | |
EP2432774A4 (en) | Compounds, compositions and methods for modulating uric acid levels | |
EP2229432A4 (en) | Antimicrobial activity of bacteriocin-producing lactic acid bacteria | |
GB0911331D0 (en) | Characterising properties or behaviour of biological cells | |
EP2393500A4 (en) | Treatment of non-oral biological tissue with chlorine dioxide | |
EP1988155A4 (en) | Lactic acid bacterium capable of producing -aminobutyric acid | |
PL2276498T3 (en) | Use of probiotic bacteria for the treatment of hyperhomocysteinaemia | |
EP2394645A4 (en) | Medical use of 5-benzylaminosalicylic acid derivatives or salts thereof | |
EP2126158A4 (en) | Manufacturing method of medical sterilized isotonic solution having low-concentratedly controlled free chlorine including hypochlorous acid therein | |
ZA201100616B (en) | Treatment of antibiotic-resistant bacteria infection | |
EP2119766A4 (en) | Agent for improving viability of lactic acid bacterium | |
SG10201405790UA (en) | Composition for lowering blood uric acid level |